Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Critical Care | 42 | 2023 | 563 | 7.300 |
Why?
|
Intensive Care Units | 51 | 2022 | 664 | 7.250 |
Why?
|
Burnout, Professional | 23 | 2023 | 333 | 6.820 |
Why?
|
Critical Illness | 36 | 2023 | 728 | 6.480 |
Why?
|
Respiratory Insufficiency | 12 | 2022 | 305 | 3.870 |
Why?
|
Respiration, Artificial | 32 | 2023 | 596 | 3.710 |
Why?
|
Survivors | 20 | 2023 | 440 | 3.580 |
Why?
|
Deglutition Disorders | 9 | 2020 | 135 | 3.440 |
Why?
|
Alcoholism | 24 | 2023 | 725 | 3.370 |
Why?
|
Nursing Staff, Hospital | 9 | 2021 | 125 | 3.310 |
Why?
|
Acute Lung Injury | 19 | 2021 | 313 | 3.300 |
Why?
|
Physical Therapy Modalities | 12 | 2019 | 283 | 3.240 |
Why?
|
Critical Care Nursing | 6 | 2020 | 32 | 3.140 |
Why?
|
Sepsis | 23 | 2023 | 546 | 3.080 |
Why?
|
Neuromuscular Blockade | 7 | 2020 | 24 | 3.040 |
Why?
|
Deglutition | 5 | 2020 | 69 | 2.760 |
Why?
|
Resilience, Psychological | 7 | 2020 | 101 | 2.740 |
Why?
|
Health Personnel | 9 | 2023 | 603 | 2.650 |
Why?
|
Stress, Psychological | 12 | 2022 | 1021 | 2.310 |
Why?
|
Respiratory Aspiration | 4 | 2020 | 36 | 2.270 |
Why?
|
Airway Extubation | 5 | 2020 | 46 | 2.120 |
Why?
|
Neuromuscular Blocking Agents | 6 | 2020 | 24 | 2.070 |
Why?
|
Hospital Mortality | 18 | 2020 | 901 | 1.840 |
Why?
|
Polyneuropathies | 5 | 2018 | 50 | 1.800 |
Why?
|
Humans | 219 | 2024 | 122796 | 1.780 |
Why?
|
Intubation, Intratracheal | 5 | 2020 | 243 | 1.770 |
Why?
|
Middle Aged | 104 | 2022 | 28563 | 1.720 |
Why?
|
Patient Discharge | 10 | 2023 | 842 | 1.720 |
Why?
|
Adaptation, Psychological | 8 | 2023 | 569 | 1.550 |
Why?
|
Delirium | 5 | 2014 | 72 | 1.540 |
Why?
|
Male | 122 | 2022 | 59639 | 1.450 |
Why?
|
APACHE | 8 | 2017 | 65 | 1.450 |
Why?
|
Female | 124 | 2022 | 63629 | 1.440 |
Why?
|
Point-of-Care Testing | 2 | 2020 | 33 | 1.330 |
Why?
|
Length of Stay | 11 | 2021 | 1077 | 1.280 |
Why?
|
Muscle Weakness | 6 | 2018 | 83 | 1.260 |
Why?
|
Neural Conduction | 4 | 2018 | 82 | 1.250 |
Why?
|
Aged | 59 | 2022 | 20495 | 1.170 |
Why?
|
Geriatric Assessment | 4 | 2013 | 187 | 1.170 |
Why?
|
Patient Acceptance of Health Care | 5 | 2019 | 707 | 1.150 |
Why?
|
Stress Disorders, Post-Traumatic | 9 | 2023 | 770 | 1.090 |
Why?
|
Adult | 77 | 2023 | 32385 | 1.060 |
Why?
|
Postoperative Complications | 7 | 2014 | 2301 | 1.040 |
Why?
|
Early Ambulation | 2 | 2022 | 15 | 1.040 |
Why?
|
Prospective Studies | 28 | 2024 | 6704 | 1.030 |
Why?
|
Frail Elderly | 4 | 2013 | 108 | 1.000 |
Why?
|
Pulmonary Medicine | 4 | 2014 | 91 | 0.980 |
Why?
|
Risk Factors | 34 | 2020 | 9381 | 0.970 |
Why?
|
Tidal Volume | 4 | 2018 | 77 | 0.940 |
Why?
|
Digestive System Surgical Procedures | 3 | 2013 | 93 | 0.930 |
Why?
|
Alcohol-Related Disorders | 5 | 2015 | 116 | 0.930 |
Why?
|
Workplace | 5 | 2021 | 225 | 0.920 |
Why?
|
Family | 4 | 2023 | 595 | 0.910 |
Why?
|
Societies, Medical | 6 | 2021 | 741 | 0.890 |
Why?
|
United States | 38 | 2022 | 13272 | 0.880 |
Why?
|
Hospitalization | 12 | 2023 | 1914 | 0.860 |
Why?
|
Shock, Septic | 4 | 2022 | 213 | 0.840 |
Why?
|
Wounds and Injuries | 5 | 2014 | 813 | 0.840 |
Why?
|
Cohort Studies | 21 | 2022 | 5294 | 0.800 |
Why?
|
Positive-Pressure Respiration | 4 | 2023 | 78 | 0.800 |
Why?
|
Tryptophan | 2 | 2014 | 140 | 0.780 |
Why?
|
Elective Surgical Procedures | 5 | 2014 | 165 | 0.770 |
Why?
|
Art Therapy | 1 | 2020 | 16 | 0.750 |
Why?
|
Glutathione | 5 | 2007 | 327 | 0.740 |
Why?
|
Blood Component Transfusion | 2 | 2011 | 83 | 0.730 |
Why?
|
Research Personnel | 4 | 2015 | 158 | 0.700 |
Why?
|
Symptom Assessment | 1 | 2020 | 124 | 0.690 |
Why?
|
Speech Therapy | 1 | 2019 | 20 | 0.690 |
Why?
|
Epidemics | 2 | 2019 | 76 | 0.690 |
Why?
|
Pulmonary Alveoli | 6 | 2013 | 395 | 0.670 |
Why?
|
Logistic Models | 11 | 2018 | 1995 | 0.660 |
Why?
|
Career Choice | 3 | 2015 | 206 | 0.660 |
Why?
|
Erythrocyte Transfusion | 3 | 2011 | 207 | 0.650 |
Why?
|
Deep Sedation | 1 | 2018 | 11 | 0.640 |
Why?
|
Risk Assessment | 11 | 2020 | 3213 | 0.640 |
Why?
|
Atracurium | 4 | 2019 | 13 | 0.640 |
Why?
|
Occupational Therapy | 1 | 2019 | 75 | 0.640 |
Why?
|
Multiple Organ Failure | 5 | 2009 | 166 | 0.630 |
Why?
|
Ventilators, Mechanical | 1 | 2018 | 52 | 0.620 |
Why?
|
Models, Organizational | 2 | 2015 | 144 | 0.620 |
Why?
|
Electromyography | 2 | 2018 | 334 | 0.620 |
Why?
|
Personnel Selection | 2 | 2015 | 77 | 0.620 |
Why?
|
Organizational Culture | 2 | 2015 | 124 | 0.620 |
Why?
|
Informed Consent | 4 | 2021 | 166 | 0.610 |
Why?
|
Pulmonary Fibrosis | 5 | 2014 | 305 | 0.600 |
Why?
|
Ethics, Nursing | 1 | 2016 | 3 | 0.580 |
Why?
|
Blood-Air Barrier | 2 | 2008 | 11 | 0.570 |
Why?
|
Third-Party Consent | 2 | 2013 | 8 | 0.570 |
Why?
|
Personal Satisfaction | 2 | 2015 | 188 | 0.560 |
Why?
|
Sleep Apnea Syndromes | 2 | 2007 | 88 | 0.560 |
Why?
|
Occupational Stress | 3 | 2021 | 34 | 0.560 |
Why?
|
Patient Readmission | 7 | 2019 | 691 | 0.550 |
Why?
|
Aged, 80 and over | 20 | 2022 | 6845 | 0.550 |
Why?
|
Hypnotics and Sedatives | 3 | 2022 | 146 | 0.540 |
Why?
|
Pneumonia | 6 | 2023 | 605 | 0.530 |
Why?
|
Patient Outcome Assessment | 1 | 2016 | 130 | 0.520 |
Why?
|
Substance Withdrawal Syndrome | 3 | 2013 | 159 | 0.520 |
Why?
|
Physical Examination | 1 | 2016 | 253 | 0.510 |
Why?
|
Institutionalization | 2 | 2011 | 13 | 0.500 |
Why?
|
Lung Diseases | 4 | 2011 | 764 | 0.500 |
Why?
|
Muscle Strength | 2 | 2017 | 290 | 0.500 |
Why?
|
Intracranial Hemorrhages | 1 | 2015 | 77 | 0.500 |
Why?
|
Antidepressive Agents, Second-Generation | 1 | 2014 | 37 | 0.500 |
Why?
|
Algorithms | 3 | 2020 | 1593 | 0.490 |
Why?
|
Retrospective Studies | 24 | 2023 | 13433 | 0.490 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2019 | 1265 | 0.480 |
Why?
|
Rectum | 2 | 2013 | 158 | 0.480 |
Why?
|
Health Promotion | 1 | 2020 | 707 | 0.470 |
Why?
|
Incidence | 14 | 2013 | 2527 | 0.470 |
Why?
|
Stem Cells | 3 | 2015 | 576 | 0.470 |
Why?
|
Alcoholic Intoxication | 1 | 2014 | 66 | 0.460 |
Why?
|
Cardiovascular Surgical Procedures | 1 | 2013 | 38 | 0.460 |
Why?
|
Recovery of Function | 1 | 2017 | 610 | 0.460 |
Why?
|
Activities of Daily Living | 2 | 2016 | 361 | 0.460 |
Why?
|
Global Health | 1 | 2016 | 352 | 0.460 |
Why?
|
Colon | 2 | 2013 | 241 | 0.450 |
Why?
|
Cross Infection | 3 | 2011 | 218 | 0.450 |
Why?
|
Speech-Language Pathology | 1 | 2012 | 21 | 0.440 |
Why?
|
Surveys and Questionnaires | 12 | 2022 | 4882 | 0.440 |
Why?
|
Health Services Accessibility | 2 | 2018 | 813 | 0.440 |
Why?
|
Predictive Value of Tests | 7 | 2020 | 1947 | 0.440 |
Why?
|
Job Satisfaction | 4 | 2022 | 175 | 0.440 |
Why?
|
Patient Admission | 1 | 2014 | 195 | 0.430 |
Why?
|
Treatment Outcome | 17 | 2022 | 9692 | 0.430 |
Why?
|
Nursing | 1 | 2012 | 33 | 0.420 |
Why?
|
Leukocytes, Mononuclear | 2 | 2017 | 514 | 0.420 |
Why?
|
Cross-Sectional Studies | 10 | 2022 | 4734 | 0.410 |
Why?
|
Transfusion Reaction | 2 | 2009 | 77 | 0.410 |
Why?
|
Health Care Costs | 3 | 2020 | 414 | 0.410 |
Why?
|
Cooperative Behavior | 5 | 2016 | 410 | 0.400 |
Why?
|
Decision Making | 2 | 2021 | 840 | 0.390 |
Why?
|
Mental Health | 1 | 2016 | 571 | 0.390 |
Why?
|
Pulmonary Surfactant-Associated Protein D | 2 | 2018 | 36 | 0.380 |
Why?
|
Mass Screening | 1 | 2018 | 1095 | 0.380 |
Why?
|
Hospital Costs | 1 | 2011 | 114 | 0.380 |
Why?
|
Patient Education as Topic | 2 | 2016 | 717 | 0.380 |
Why?
|
Patient Preference | 1 | 2012 | 170 | 0.380 |
Why?
|
Practice Patterns, Physicians' | 2 | 2019 | 1267 | 0.380 |
Why?
|
Psychomotor Agitation | 1 | 2011 | 75 | 0.380 |
Why?
|
Hydroxychloroquine | 2 | 2020 | 58 | 0.370 |
Why?
|
Nervous System Diseases | 1 | 2013 | 265 | 0.370 |
Why?
|
Extravascular Lung Water | 3 | 2009 | 11 | 0.370 |
Why?
|
Drug Overdose | 1 | 2014 | 273 | 0.370 |
Why?
|
Exercise Test | 2 | 2014 | 588 | 0.370 |
Why?
|
Program Evaluation | 1 | 2014 | 880 | 0.370 |
Why?
|
Multivariate Analysis | 9 | 2018 | 1531 | 0.370 |
Why?
|
Lymphoid Progenitor Cells | 1 | 2009 | 11 | 0.360 |
Why?
|
Biomedical Research | 2 | 2014 | 630 | 0.360 |
Why?
|
Leptin | 1 | 2011 | 233 | 0.360 |
Why?
|
Brain Injuries | 1 | 2015 | 488 | 0.360 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2010 | 113 | 0.350 |
Why?
|
Congresses as Topic | 1 | 2011 | 208 | 0.350 |
Why?
|
Secondary Prevention | 1 | 2011 | 257 | 0.350 |
Why?
|
Pneumonia, Bacterial | 2 | 2007 | 113 | 0.350 |
Why?
|
Depression | 4 | 2020 | 1190 | 0.350 |
Why?
|
ROC Curve | 5 | 2017 | 494 | 0.350 |
Why?
|
Homeostasis | 2 | 2003 | 596 | 0.350 |
Why?
|
Biomarkers | 11 | 2018 | 3662 | 0.340 |
Why?
|
Colorado | 8 | 2018 | 4325 | 0.340 |
Why?
|
Occupational Exposure | 1 | 2012 | 298 | 0.340 |
Why?
|
Lung | 9 | 2017 | 3830 | 0.340 |
Why?
|
Pleural Diseases | 1 | 2008 | 22 | 0.330 |
Why?
|
Cognition Disorders | 2 | 2016 | 547 | 0.330 |
Why?
|
Physicians | 3 | 2022 | 824 | 0.330 |
Why?
|
Patient Positioning | 2 | 2022 | 53 | 0.330 |
Why?
|
Sensitivity and Specificity | 5 | 2017 | 1855 | 0.330 |
Why?
|
Asthma | 4 | 2022 | 2130 | 0.330 |
Why?
|
Time Factors | 8 | 2017 | 6682 | 0.330 |
Why?
|
Prognosis | 11 | 2016 | 3563 | 0.320 |
Why?
|
Prevalence | 6 | 2020 | 2442 | 0.320 |
Why?
|
Comorbidity | 9 | 2020 | 1600 | 0.320 |
Why?
|
Bronchoalveolar Lavage Fluid | 10 | 2012 | 633 | 0.320 |
Why?
|
Cause of Death | 3 | 2017 | 389 | 0.320 |
Why?
|
Pulmonary Embolism | 3 | 2019 | 190 | 0.320 |
Why?
|
Severity of Illness Index | 10 | 2018 | 2784 | 0.310 |
Why?
|
Proxy | 2 | 2021 | 22 | 0.310 |
Why?
|
Emergency Medical Services | 2 | 2012 | 635 | 0.310 |
Why?
|
Smoking Cessation | 1 | 2011 | 363 | 0.310 |
Why?
|
Respiratory Tract Infections | 2 | 2008 | 335 | 0.300 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 551 | 0.300 |
Why?
|
Alcohol-Induced Disorders, Nervous System | 1 | 2006 | 6 | 0.300 |
Why?
|
Specialties, Nursing | 1 | 2006 | 9 | 0.300 |
Why?
|
Surgical Procedures, Operative | 1 | 2009 | 227 | 0.290 |
Why?
|
Follow-Up Studies | 9 | 2016 | 4768 | 0.290 |
Why?
|
Immunocompromised Host | 1 | 2008 | 205 | 0.290 |
Why?
|
Blood Gas Analysis | 2 | 2017 | 79 | 0.290 |
Why?
|
Dose-Response Relationship, Drug | 7 | 2020 | 1981 | 0.290 |
Why?
|
Tissue Plasminogen Activator | 2 | 2018 | 242 | 0.280 |
Why?
|
Tuberculosis, Pulmonary | 1 | 2007 | 127 | 0.280 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2008 | 141 | 0.280 |
Why?
|
Mental Disorders | 1 | 2014 | 952 | 0.280 |
Why?
|
Anxiety | 4 | 2023 | 888 | 0.280 |
Why?
|
Antitubercular Agents | 1 | 2007 | 167 | 0.280 |
Why?
|
Pulmonary Edema | 3 | 2013 | 141 | 0.270 |
Why?
|
Mindfulness | 2 | 2020 | 103 | 0.270 |
Why?
|
Disability Evaluation | 5 | 2016 | 291 | 0.270 |
Why?
|
Clinical Trials as Topic | 4 | 2021 | 985 | 0.270 |
Why?
|
Mentors | 4 | 2015 | 170 | 0.260 |
Why?
|
Neuromuscular Diseases | 1 | 2006 | 89 | 0.260 |
Why?
|
Drug Delivery Systems | 1 | 2008 | 312 | 0.250 |
Why?
|
Lung Neoplasms | 2 | 2008 | 2216 | 0.250 |
Why?
|
Diagnostic Imaging | 1 | 2007 | 310 | 0.250 |
Why?
|
Education, Continuing | 3 | 2015 | 42 | 0.250 |
Why?
|
Analysis of Variance | 3 | 2018 | 1329 | 0.250 |
Why?
|
Inflammation | 3 | 2017 | 2598 | 0.250 |
Why?
|
Reproducibility of Results | 5 | 2024 | 2977 | 0.240 |
Why?
|
Education, Medical, Graduate | 1 | 2008 | 432 | 0.240 |
Why?
|
Lung Diseases, Interstitial | 2 | 2010 | 465 | 0.230 |
Why?
|
Multimorbidity | 1 | 2023 | 31 | 0.230 |
Why?
|
Interferons | 2 | 2016 | 154 | 0.230 |
Why?
|
Oximetry | 3 | 2024 | 96 | 0.230 |
Why?
|
Pulmonary Surfactant-Associated Protein A | 1 | 2003 | 26 | 0.230 |
Why?
|
Cost of Illness | 2 | 2020 | 284 | 0.230 |
Why?
|
Liver Cirrhosis, Alcoholic | 1 | 2002 | 19 | 0.220 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2003 | 82 | 0.220 |
Why?
|
Liver Transplantation | 1 | 2011 | 929 | 0.220 |
Why?
|
Randomized Controlled Trials as Topic | 5 | 2023 | 1260 | 0.220 |
Why?
|
Permeability | 3 | 2013 | 155 | 0.220 |
Why?
|
Propensity Score | 3 | 2022 | 253 | 0.220 |
Why?
|
Personnel Turnover | 1 | 2022 | 28 | 0.210 |
Why?
|
Curriculum | 3 | 2020 | 925 | 0.210 |
Why?
|
Quality of Life | 7 | 2023 | 2457 | 0.210 |
Why?
|
Muscular Diseases | 2 | 2017 | 108 | 0.210 |
Why?
|
Lung Injury | 2 | 2015 | 215 | 0.210 |
Why?
|
Prone Position | 1 | 2022 | 53 | 0.210 |
Why?
|
Occupational Health | 2 | 2016 | 175 | 0.210 |
Why?
|
Occupational Therapists | 1 | 2021 | 4 | 0.210 |
Why?
|
Combined Modality Therapy | 4 | 2019 | 1174 | 0.210 |
Why?
|
Motivation | 3 | 2015 | 515 | 0.210 |
Why?
|
Double-Blind Method | 7 | 2014 | 1711 | 0.200 |
Why?
|
Patient Satisfaction | 2 | 2016 | 632 | 0.200 |
Why?
|
Liver Cirrhosis | 1 | 2003 | 252 | 0.200 |
Why?
|
Databases, Factual | 2 | 2019 | 1287 | 0.200 |
Why?
|
Psychosocial Support Systems | 1 | 2021 | 10 | 0.200 |
Why?
|
Interleukin-8 | 3 | 2018 | 256 | 0.200 |
Why?
|
Compassion Fatigue | 1 | 2021 | 22 | 0.190 |
Why?
|
Publishing | 1 | 2003 | 161 | 0.190 |
Why?
|
Hypoxia | 3 | 2017 | 1003 | 0.190 |
Why?
|
Neutrophils | 3 | 2017 | 1246 | 0.190 |
Why?
|
Mobile Applications | 1 | 2023 | 155 | 0.190 |
Why?
|
Attitude of Health Personnel | 3 | 2019 | 1012 | 0.190 |
Why?
|
Financing, Personal | 1 | 2020 | 29 | 0.190 |
Why?
|
Decision Trees | 1 | 2020 | 95 | 0.190 |
Why?
|
Schools, Nursing | 1 | 2020 | 11 | 0.190 |
Why?
|
Noninvasive Ventilation | 1 | 2020 | 31 | 0.190 |
Why?
|
Anxiety Disorders | 1 | 2023 | 326 | 0.190 |
Why?
|
Workload | 1 | 2021 | 132 | 0.180 |
Why?
|
Professional Role | 1 | 2021 | 162 | 0.180 |
Why?
|
Preoperative Care | 2 | 2013 | 342 | 0.180 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2013 | 2221 | 0.180 |
Why?
|
Radiography, Thoracic | 3 | 2014 | 168 | 0.180 |
Why?
|
Endothelial Cells | 1 | 2005 | 749 | 0.180 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2022 | 249 | 0.180 |
Why?
|
Emergency Service, Hospital | 3 | 2017 | 1922 | 0.180 |
Why?
|
Australia | 2 | 2014 | 223 | 0.180 |
Why?
|
Research | 1 | 2003 | 432 | 0.180 |
Why?
|
Young Adult | 10 | 2021 | 11094 | 0.170 |
Why?
|
Sex Factors | 6 | 2018 | 1860 | 0.170 |
Why?
|
Infection Control | 1 | 2020 | 138 | 0.170 |
Why?
|
Program Development | 3 | 2015 | 372 | 0.170 |
Why?
|
Foundations | 1 | 2018 | 20 | 0.170 |
Why?
|
Staff Development | 2 | 2015 | 41 | 0.170 |
Why?
|
Smoke-Free Policy | 1 | 2018 | 15 | 0.170 |
Why?
|
Unnecessary Procedures | 1 | 2019 | 49 | 0.170 |
Why?
|
Macrolides | 1 | 2019 | 66 | 0.170 |
Why?
|
Case-Control Studies | 9 | 2018 | 3296 | 0.170 |
Why?
|
Capillaries | 2 | 2009 | 107 | 0.160 |
Why?
|
RNA, Messenger | 4 | 2017 | 2720 | 0.160 |
Why?
|
Health Care Surveys | 2 | 2012 | 564 | 0.160 |
Why?
|
Endothelium, Vascular | 1 | 2005 | 923 | 0.160 |
Why?
|
Vecuronium Bromide | 1 | 2018 | 6 | 0.160 |
Why?
|
Physicians, Women | 1 | 2019 | 53 | 0.160 |
Why?
|
Pandemics | 3 | 2022 | 1401 | 0.160 |
Why?
|
Pulmonary Ventilation | 2 | 2018 | 72 | 0.160 |
Why?
|
Tobacco Industry | 1 | 2018 | 45 | 0.160 |
Why?
|
Heart Failure, Systolic | 1 | 2018 | 20 | 0.160 |
Why?
|
Social Responsibility | 1 | 2018 | 51 | 0.160 |
Why?
|
Heart Failure, Diastolic | 1 | 2018 | 22 | 0.160 |
Why?
|
Internship and Residency | 1 | 2008 | 1065 | 0.160 |
Why?
|
Career Mobility | 2 | 2015 | 67 | 0.160 |
Why?
|
von Willebrand Factor | 1 | 2018 | 59 | 0.160 |
Why?
|
Dyspnea | 1 | 2019 | 214 | 0.160 |
Why?
|
Cardiologists | 1 | 2018 | 41 | 0.160 |
Why?
|
Hospital Charges | 1 | 2017 | 46 | 0.160 |
Why?
|
Inservice Training | 2 | 2015 | 105 | 0.160 |
Why?
|
Age Factors | 5 | 2018 | 3114 | 0.160 |
Why?
|
Socioeconomic Factors | 3 | 2018 | 1158 | 0.150 |
Why?
|
Precision Medicine | 1 | 2021 | 371 | 0.150 |
Why?
|
Equipment Failure | 1 | 2018 | 116 | 0.150 |
Why?
|
Heparin | 1 | 2019 | 240 | 0.150 |
Why?
|
Bayes Theorem | 1 | 2019 | 363 | 0.150 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3388 | 0.150 |
Why?
|
Adaptation, Physiological | 1 | 2021 | 510 | 0.150 |
Why?
|
Betacoronavirus | 1 | 2020 | 265 | 0.150 |
Why?
|
Peer Group | 2 | 2015 | 208 | 0.150 |
Why?
|
Emotions | 2 | 2021 | 524 | 0.150 |
Why?
|
Myosin-Light-Chain Kinase | 2 | 2007 | 26 | 0.150 |
Why?
|
Psychology, Industrial | 1 | 2016 | 2 | 0.150 |
Why?
|
Toll-Like Receptors | 1 | 2017 | 169 | 0.140 |
Why?
|
Hospitals, University | 2 | 2009 | 183 | 0.140 |
Why?
|
Subacute Care | 1 | 2017 | 75 | 0.140 |
Why?
|
Pamphlets | 1 | 2016 | 25 | 0.140 |
Why?
|
Electrophysiological Phenomena | 1 | 2016 | 53 | 0.140 |
Why?
|
Survival Analysis | 4 | 2016 | 1325 | 0.140 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2023 | 2127 | 0.140 |
Why?
|
Clinical Decision-Making | 1 | 2019 | 293 | 0.140 |
Why?
|
Georgia | 3 | 2005 | 62 | 0.140 |
Why?
|
Continuity of Patient Care | 1 | 2018 | 276 | 0.140 |
Why?
|
Intersectoral Collaboration | 1 | 2016 | 61 | 0.140 |
Why?
|
Exercise Therapy | 1 | 2020 | 375 | 0.140 |
Why?
|
Opioid-Related Disorders | 1 | 2023 | 412 | 0.140 |
Why?
|
Delivery of Health Care | 1 | 2023 | 915 | 0.140 |
Why?
|
Fibrinolytic Agents | 1 | 2018 | 257 | 0.140 |
Why?
|
RNA Splicing | 1 | 2017 | 250 | 0.140 |
Why?
|
Interviews as Topic | 2 | 2020 | 601 | 0.140 |
Why?
|
Alternative Splicing | 1 | 2017 | 197 | 0.140 |
Why?
|
Education, Graduate | 1 | 2015 | 37 | 0.140 |
Why?
|
Pilot Projects | 3 | 2023 | 1477 | 0.130 |
Why?
|
Interpersonal Relations | 2 | 2015 | 351 | 0.130 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 239 | 0.130 |
Why?
|
Nurse's Role | 1 | 2016 | 102 | 0.130 |
Why?
|
Neurophysiological Monitoring | 1 | 2015 | 10 | 0.130 |
Why?
|
France | 2 | 2005 | 38 | 0.130 |
Why?
|
Guideline Adherence | 1 | 2019 | 560 | 0.130 |
Why?
|
Hospitals, Community | 1 | 2015 | 48 | 0.130 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 361 | 0.130 |
Why?
|
Coronavirus Infections | 1 | 2020 | 349 | 0.130 |
Why?
|
Seasons | 2 | 2008 | 468 | 0.130 |
Why?
|
Hospitals, Teaching | 1 | 2015 | 114 | 0.130 |
Why?
|
Intracranial Pressure | 1 | 2015 | 54 | 0.130 |
Why?
|
Craniotomy | 1 | 2015 | 69 | 0.130 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2012 | 153 | 0.120 |
Why?
|
Social Support | 1 | 2018 | 547 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2016 | 144 | 0.120 |
Why?
|
Health Surveys | 2 | 2009 | 468 | 0.120 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 2491 | 0.120 |
Why?
|
Chronic Disease | 5 | 2018 | 1645 | 0.120 |
Why?
|
Sural Nerve | 1 | 2014 | 20 | 0.120 |
Why?
|
Ultrasonography | 1 | 2018 | 740 | 0.120 |
Why?
|
Peroneal Nerve | 1 | 2014 | 19 | 0.120 |
Why?
|
Glasgow Coma Scale | 1 | 2015 | 160 | 0.120 |
Why?
|
Anticoagulants | 1 | 2019 | 589 | 0.120 |
Why?
|
Ethanol | 2 | 2010 | 584 | 0.120 |
Why?
|
Survival Rate | 4 | 2011 | 1810 | 0.120 |
Why?
|
Epithelial Cells | 2 | 2017 | 995 | 0.120 |
Why?
|
Methylprednisolone | 1 | 2014 | 86 | 0.120 |
Why?
|
Forms and Records Control | 1 | 2013 | 23 | 0.120 |
Why?
|
Statistics, Nonparametric | 3 | 2004 | 416 | 0.120 |
Why?
|
Tomography, X-Ray Computed | 2 | 2014 | 2500 | 0.120 |
Why?
|
Public Health | 1 | 2018 | 480 | 0.120 |
Why?
|
Neurologic Examination | 1 | 2014 | 127 | 0.120 |
Why?
|
Animals | 12 | 2017 | 34133 | 0.120 |
Why?
|
Electrophysiology | 1 | 2014 | 205 | 0.120 |
Why?
|
Melatonin | 1 | 2014 | 110 | 0.120 |
Why?
|
Hemorrhage | 2 | 2019 | 663 | 0.120 |
Why?
|
Research Design | 3 | 2014 | 1002 | 0.110 |
Why?
|
Ventilator Weaning | 1 | 2013 | 33 | 0.110 |
Why?
|
Growth Differentiation Factor 15 | 1 | 2013 | 36 | 0.110 |
Why?
|
Oxidative Stress | 2 | 2012 | 1204 | 0.110 |
Why?
|
Postoperative Care | 1 | 2014 | 245 | 0.110 |
Why?
|
Macrophages, Alveolar | 3 | 2010 | 364 | 0.110 |
Why?
|
Academic Medical Centers | 2 | 2012 | 427 | 0.110 |
Why?
|
Outpatients | 1 | 2016 | 336 | 0.110 |
Why?
|
Forecasting | 1 | 2014 | 372 | 0.110 |
Why?
|
Tape Recording | 1 | 2012 | 12 | 0.110 |
Why?
|
Perception | 1 | 2015 | 324 | 0.110 |
Why?
|
Odds Ratio | 2 | 2016 | 1043 | 0.110 |
Why?
|
Serotonin | 1 | 2014 | 311 | 0.110 |
Why?
|
Bed Rest | 1 | 2012 | 16 | 0.110 |
Why?
|
Drugs, Chinese Herbal | 1 | 2012 | 17 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2012 | 95 | 0.110 |
Why?
|
Neuregulin-1 | 1 | 2012 | 43 | 0.100 |
Why?
|
Uteroglobin | 2 | 2014 | 17 | 0.100 |
Why?
|
Nursing Homes | 1 | 2013 | 137 | 0.100 |
Why?
|
Observer Variation | 1 | 2012 | 314 | 0.100 |
Why?
|
Telemedicine | 1 | 2020 | 691 | 0.100 |
Why?
|
Counseling | 1 | 2014 | 364 | 0.100 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2011 | 34 | 0.100 |
Why?
|
Practice Guidelines as Topic | 1 | 2019 | 1519 | 0.100 |
Why?
|
Adolescent | 7 | 2022 | 18948 | 0.100 |
Why?
|
Albuterol | 1 | 2011 | 103 | 0.100 |
Why?
|
Pediatric Nursing | 1 | 2011 | 41 | 0.100 |
Why?
|
Data Collection | 2 | 2011 | 667 | 0.100 |
Why?
|
Genetic Testing | 1 | 2013 | 400 | 0.100 |
Why?
|
Professional-Family Relations | 1 | 2012 | 141 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2011 | 839 | 0.100 |
Why?
|
MicroRNAs | 1 | 2017 | 661 | 0.100 |
Why?
|
Comparative Effectiveness Research | 1 | 2011 | 142 | 0.100 |
Why?
|
Self Report | 1 | 2014 | 730 | 0.090 |
Why?
|
Adrenal Cortex Hormones | 1 | 2014 | 515 | 0.090 |
Why?
|
Risk | 3 | 2018 | 890 | 0.090 |
Why?
|
Enteral Nutrition | 1 | 2012 | 174 | 0.090 |
Why?
|
Colony-Forming Units Assay | 1 | 2009 | 95 | 0.090 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2010 | 80 | 0.090 |
Why?
|
Medical Staff, Hospital | 1 | 2010 | 79 | 0.090 |
Why?
|
Data Interpretation, Statistical | 2 | 2017 | 345 | 0.090 |
Why?
|
Decision Support Techniques | 1 | 2013 | 392 | 0.090 |
Why?
|
Lung Compliance | 1 | 2009 | 50 | 0.090 |
Why?
|
Alcohol Drinking | 1 | 2015 | 668 | 0.090 |
Why?
|
Patient Selection | 1 | 2013 | 717 | 0.090 |
Why?
|
Walking | 1 | 2013 | 435 | 0.090 |
Why?
|
Physician's Role | 1 | 2011 | 207 | 0.090 |
Why?
|
Caregivers | 1 | 2016 | 723 | 0.090 |
Why?
|
Trauma Centers | 2 | 2009 | 399 | 0.090 |
Why?
|
Anti-Bacterial Agents | 1 | 2019 | 1562 | 0.090 |
Why?
|
Thermodilution | 2 | 2008 | 13 | 0.090 |
Why?
|
Physician-Nurse Relations | 1 | 2009 | 14 | 0.090 |
Why?
|
Internal Medicine | 1 | 2011 | 226 | 0.090 |
Why?
|
Leisure Activities | 1 | 2009 | 28 | 0.090 |
Why?
|
Energy Intake | 1 | 2012 | 453 | 0.090 |
Why?
|
Treatment Failure | 2 | 2020 | 348 | 0.080 |
Why?
|
Toll-Like Receptor 1 | 1 | 2008 | 12 | 0.080 |
Why?
|
Technetium Tc 99m Pentetate | 1 | 2008 | 7 | 0.080 |
Why?
|
Radionuclide Imaging | 2 | 2008 | 134 | 0.080 |
Why?
|
Nurse Administrators | 1 | 2009 | 33 | 0.080 |
Why?
|
Cardiac Surgical Procedures | 1 | 2013 | 477 | 0.080 |
Why?
|
Genetic Predisposition to Disease | 2 | 2008 | 2359 | 0.080 |
Why?
|
Faculty, Medical | 1 | 2011 | 258 | 0.080 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2009 | 84 | 0.080 |
Why?
|
Phagocytosis | 1 | 2010 | 368 | 0.080 |
Why?
|
Quality Improvement | 1 | 2016 | 1004 | 0.080 |
Why?
|
Psychometrics | 1 | 2012 | 672 | 0.080 |
Why?
|
Half-Life | 1 | 2008 | 147 | 0.080 |
Why?
|
Hospitals, Urban | 2 | 2018 | 140 | 0.080 |
Why?
|
Pulmonary Artery | 2 | 2013 | 1097 | 0.080 |
Why?
|
Mental Recall | 2 | 2021 | 185 | 0.080 |
Why?
|
Macrophage Migration-Inhibitory Factors | 1 | 2007 | 14 | 0.080 |
Why?
|
Staphylococcus aureus | 1 | 2011 | 400 | 0.080 |
Why?
|
Health Behavior | 1 | 2013 | 731 | 0.080 |
Why?
|
Feasibility Studies | 2 | 2023 | 780 | 0.080 |
Why?
|
Qualitative Research | 1 | 2012 | 950 | 0.080 |
Why?
|
Sleep Wake Disorders | 1 | 2011 | 289 | 0.080 |
Why?
|
Databases as Topic | 1 | 2007 | 79 | 0.080 |
Why?
|
Cocaine-Related Disorders | 1 | 2008 | 110 | 0.080 |
Why?
|
Intramolecular Oxidoreductases | 1 | 2007 | 61 | 0.080 |
Why?
|
Radiopharmaceuticals | 1 | 2008 | 196 | 0.080 |
Why?
|
Respiration Disorders | 1 | 2007 | 67 | 0.070 |
Why?
|
Pharmacoepidemiology | 2 | 2019 | 22 | 0.070 |
Why?
|
Plasma | 1 | 2009 | 223 | 0.070 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2008 | 70 | 0.070 |
Why?
|
Social Environment | 1 | 2009 | 301 | 0.070 |
Why?
|
Hemodynamics | 3 | 2009 | 1036 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2013 | 842 | 0.070 |
Why?
|
Fibronectins | 1 | 2007 | 115 | 0.070 |
Why?
|
Morbidity | 1 | 2007 | 309 | 0.070 |
Why?
|
Flow Cytometry | 1 | 2009 | 1128 | 0.070 |
Why?
|
Hypoproteinemia | 1 | 2005 | 5 | 0.070 |
Why?
|
England | 1 | 2005 | 72 | 0.070 |
Why?
|
Polysomnography | 1 | 2006 | 177 | 0.070 |
Why?
|
Furosemide | 1 | 2005 | 34 | 0.070 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2005 | 55 | 0.070 |
Why?
|
Gene Expression | 1 | 2010 | 1506 | 0.070 |
Why?
|
Diuretics | 1 | 2005 | 78 | 0.070 |
Why?
|
Linkage Disequilibrium | 1 | 2006 | 279 | 0.070 |
Why?
|
Probability | 1 | 2006 | 316 | 0.060 |
Why?
|
Age Distribution | 1 | 2006 | 376 | 0.060 |
Why?
|
Sex Distribution | 1 | 2006 | 370 | 0.060 |
Why?
|
Neoplasm Staging | 1 | 2008 | 1234 | 0.060 |
Why?
|
Serum Albumin | 1 | 2005 | 151 | 0.060 |
Why?
|
Virus Diseases | 1 | 2007 | 201 | 0.060 |
Why?
|
Wounds, Penetrating | 1 | 2005 | 79 | 0.060 |
Why?
|
Sleep Deprivation | 1 | 2006 | 174 | 0.060 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2010 | 456 | 0.060 |
Why?
|
Metabolic Syndrome | 1 | 2008 | 395 | 0.060 |
Why?
|
Cells, Cultured | 3 | 2010 | 4162 | 0.060 |
Why?
|
E-Selectin | 1 | 2004 | 53 | 0.060 |
Why?
|
New Zealand | 1 | 2004 | 53 | 0.060 |
Why?
|
Signal Transduction | 1 | 2017 | 4902 | 0.060 |
Why?
|
Exercise | 1 | 2014 | 1743 | 0.060 |
Why?
|
Disease-Free Survival | 2 | 2018 | 661 | 0.060 |
Why?
|
Oxygen | 3 | 2024 | 887 | 0.060 |
Why?
|
Xanthine Dehydrogenase | 1 | 2023 | 34 | 0.060 |
Why?
|
Cell Separation | 2 | 2016 | 303 | 0.060 |
Why?
|
Washington | 1 | 2003 | 139 | 0.060 |
Why?
|
Cytokines | 3 | 2017 | 1928 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 884 | 0.050 |
Why?
|
Immunity, Innate | 1 | 2008 | 762 | 0.050 |
Why?
|
Wounds, Nonpenetrating | 1 | 2005 | 290 | 0.050 |
Why?
|
Mice | 5 | 2011 | 15888 | 0.050 |
Why?
|
Longitudinal Studies | 2 | 2006 | 2599 | 0.050 |
Why?
|
North America | 1 | 2022 | 271 | 0.050 |
Why?
|
Vasopressins | 1 | 2022 | 64 | 0.050 |
Why?
|
Vasoconstrictor Agents | 1 | 2022 | 128 | 0.050 |
Why?
|
Aftercare | 1 | 2023 | 203 | 0.050 |
Why?
|
Moral Obligations | 1 | 2021 | 11 | 0.050 |
Why?
|
Norepinephrine | 1 | 2022 | 214 | 0.050 |
Why?
|
Critical Care Outcomes | 1 | 2020 | 13 | 0.050 |
Why?
|
Status Asthmaticus | 1 | 2020 | 11 | 0.050 |
Why?
|
Respiratory Mucosa | 1 | 2003 | 263 | 0.050 |
Why?
|
Allied Health Personnel | 1 | 2021 | 49 | 0.050 |
Why?
|
Antimalarials | 1 | 2020 | 24 | 0.050 |
Why?
|
Apoptosis | 1 | 2010 | 2532 | 0.050 |
Why?
|
Disease Progression | 2 | 2020 | 2546 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2009 | 985 | 0.050 |
Why?
|
Trust | 1 | 2021 | 112 | 0.050 |
Why?
|
Sampling Studies | 1 | 2020 | 95 | 0.050 |
Why?
|
Veterans Health | 1 | 2021 | 167 | 0.050 |
Why?
|
Single-Blind Method | 1 | 2020 | 275 | 0.040 |
Why?
|
Minority Groups | 1 | 2021 | 242 | 0.040 |
Why?
|
Acute Disease | 1 | 2002 | 984 | 0.040 |
Why?
|
Meta-Analysis as Topic | 1 | 2020 | 172 | 0.040 |
Why?
|
Income | 1 | 2020 | 181 | 0.040 |
Why?
|
Child | 5 | 2022 | 19561 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2011 | 757 | 0.040 |
Why?
|
Education, Nursing | 1 | 2020 | 79 | 0.040 |
Why?
|
Insurance Coverage | 1 | 2020 | 218 | 0.040 |
Why?
|
Tennessee | 1 | 2018 | 45 | 0.040 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2018 | 46 | 0.040 |
Why?
|
Sexism | 1 | 2019 | 50 | 0.040 |
Why?
|
Conscious Sedation | 1 | 2019 | 84 | 0.040 |
Why?
|
Smoking | 3 | 2015 | 1556 | 0.040 |
Why?
|
Coronary Circulation | 1 | 2018 | 121 | 0.040 |
Why?
|
Mice, Inbred C57BL | 3 | 2017 | 5020 | 0.040 |
Why?
|
Hospitals, Rural | 1 | 2018 | 36 | 0.040 |
Why?
|
Observation | 2 | 2011 | 55 | 0.040 |
Why?
|
Insurance, Health | 1 | 2020 | 259 | 0.040 |
Why?
|
Minnesota | 1 | 2018 | 143 | 0.040 |
Why?
|
RNA Transport | 1 | 2017 | 22 | 0.040 |
Why?
|
Genotype | 1 | 2023 | 1943 | 0.040 |
Why?
|
Safety-net Providers | 1 | 2018 | 106 | 0.040 |
Why?
|
Poly(ADP-ribose) Polymerases | 1 | 2017 | 88 | 0.040 |
Why?
|
Venous Thrombosis | 1 | 2019 | 148 | 0.040 |
Why?
|
Thrombocytopenia | 1 | 2019 | 188 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 2 | 2010 | 1003 | 0.040 |
Why?
|
Sample Size | 1 | 2017 | 135 | 0.040 |
Why?
|
Gene Knockdown Techniques | 1 | 2017 | 322 | 0.040 |
Why?
|
RNA Precursors | 1 | 2017 | 142 | 0.040 |
Why?
|
Partial Pressure | 1 | 2016 | 32 | 0.040 |
Why?
|
Cell Communication | 1 | 2017 | 287 | 0.030 |
Why?
|
Fibroblasts | 2 | 2013 | 846 | 0.030 |
Why?
|
Radiation Effects | 1 | 1975 | 4 | 0.030 |
Why?
|
Cosmic Radiation | 1 | 1975 | 8 | 0.030 |
Why?
|
Capacity Building | 1 | 2015 | 53 | 0.030 |
Why?
|
Syndrome | 1 | 2016 | 363 | 0.030 |
Why?
|
Interferon-alpha | 1 | 2016 | 190 | 0.030 |
Why?
|
Models, Educational | 1 | 2015 | 100 | 0.030 |
Why?
|
Nonlinear Dynamics | 1 | 2016 | 92 | 0.030 |
Why?
|
Ventricular Function, Left | 1 | 2018 | 493 | 0.030 |
Why?
|
Mood Disorders | 1 | 2016 | 122 | 0.030 |
Why?
|
Tooth | 1 | 1975 | 41 | 0.030 |
Why?
|
Mouth | 1 | 1975 | 81 | 0.030 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2014 | 31 | 0.030 |
Why?
|
Haplotypes | 2 | 2007 | 482 | 0.030 |
Why?
|
Mortality | 1 | 2017 | 317 | 0.030 |
Why?
|
Interdisciplinary Communication | 1 | 2015 | 195 | 0.030 |
Why?
|
Nitrates | 1 | 2014 | 80 | 0.030 |
Why?
|
Nitrites | 1 | 2014 | 81 | 0.030 |
Why?
|
Respiratory Function Tests | 1 | 2016 | 563 | 0.030 |
Why?
|
Pulmonary Diffusing Capacity | 2 | 2013 | 62 | 0.030 |
Why?
|
Space Flight | 1 | 1975 | 130 | 0.030 |
Why?
|
Mental Competency | 1 | 2013 | 26 | 0.030 |
Why?
|
Catheterization, Swan-Ganz | 1 | 2013 | 8 | 0.030 |
Why?
|
Nanoparticles | 1 | 2017 | 329 | 0.030 |
Why?
|
Cognition | 1 | 2021 | 1066 | 0.030 |
Why?
|
Total Lung Capacity | 1 | 2013 | 38 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2013 | 247 | 0.030 |
Why?
|
Transcription, Genetic | 2 | 2010 | 1355 | 0.030 |
Why?
|
Healthcare Disparities | 1 | 2018 | 494 | 0.030 |
Why?
|
Fibrosis | 1 | 2015 | 497 | 0.030 |
Why?
|
Electrodiagnosis | 1 | 2012 | 15 | 0.030 |
Why?
|
Vital Capacity | 1 | 2013 | 277 | 0.030 |
Why?
|
Bone and Bones | 1 | 1975 | 296 | 0.030 |
Why?
|
United States Department of Veterans Affairs | 1 | 2016 | 564 | 0.030 |
Why?
|
Fluid Therapy | 1 | 2013 | 149 | 0.030 |
Why?
|
Respiratory Muscles | 1 | 2012 | 37 | 0.030 |
Why?
|
Neoplasms | 1 | 2006 | 2235 | 0.030 |
Why?
|
Documentation | 1 | 2013 | 180 | 0.030 |
Why?
|
Lipid Peroxidation | 1 | 2012 | 151 | 0.030 |
Why?
|
Phytotherapy | 1 | 2012 | 72 | 0.030 |
Why?
|
Hospital Units | 1 | 2011 | 24 | 0.030 |
Why?
|
Mobility Limitation | 1 | 2012 | 66 | 0.030 |
Why?
|
Nursing Methodology Research | 1 | 2011 | 46 | 0.030 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 1 | 2011 | 101 | 0.030 |
Why?
|
Muscular Atrophy | 1 | 2012 | 85 | 0.020 |
Why?
|
Epithelium | 1 | 2012 | 309 | 0.020 |
Why?
|
Extracellular Matrix | 1 | 2015 | 461 | 0.020 |
Why?
|
Muscle Fatigue | 1 | 2012 | 92 | 0.020 |
Why?
|
Microbial Viability | 1 | 2011 | 82 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 2012 | 396 | 0.020 |
Why?
|
Bronchoalveolar Lavage | 1 | 2010 | 98 | 0.020 |
Why?
|
Night Care | 1 | 2010 | 5 | 0.020 |
Why?
|
Research Support as Topic | 1 | 2011 | 122 | 0.020 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2014 | 249 | 0.020 |
Why?
|
Superoxides | 1 | 2011 | 225 | 0.020 |
Why?
|
Community Participation | 1 | 2011 | 125 | 0.020 |
Why?
|
After-Hours Care | 1 | 2010 | 16 | 0.020 |
Why?
|
Health Plan Implementation | 1 | 2011 | 132 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 469 | 0.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2011 | 290 | 0.020 |
Why?
|
rhoA GTP-Binding Protein | 1 | 2010 | 80 | 0.020 |
Why?
|
Viruses | 1 | 2011 | 98 | 0.020 |
Why?
|
rho GTP-Binding Proteins | 1 | 2010 | 68 | 0.020 |
Why?
|
Amides | 1 | 2010 | 88 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 578 | 0.020 |
Why?
|
Receptor, ErbB-2 | 1 | 2012 | 321 | 0.020 |
Why?
|
rho-Associated Kinases | 1 | 2010 | 85 | 0.020 |
Why?
|
Cell Death | 1 | 2011 | 345 | 0.020 |
Why?
|
Administration, Inhalation | 1 | 2011 | 664 | 0.020 |
Why?
|
Gastrointestinal Tract | 1 | 2012 | 176 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2016 | 1625 | 0.020 |
Why?
|
Parity | 1 | 2009 | 108 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2014 | 884 | 0.020 |
Why?
|
Vascular Resistance | 1 | 2010 | 374 | 0.020 |
Why?
|
Trauma Severity Indices | 1 | 2008 | 128 | 0.020 |
Why?
|
Gram-Negative Bacterial Infections | 1 | 2008 | 39 | 0.020 |
Why?
|
Recombinant Proteins | 1 | 2012 | 1318 | 0.020 |
Why?
|
Antioxidants | 1 | 2012 | 581 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2012 | 702 | 0.020 |
Why?
|
Breath Tests | 1 | 2007 | 87 | 0.020 |
Why?
|
Caribbean Region | 1 | 2007 | 24 | 0.020 |
Why?
|
Hospitals, Pediatric | 1 | 2011 | 507 | 0.020 |
Why?
|
Quality Assurance, Health Care | 1 | 2010 | 362 | 0.020 |
Why?
|
Tissue Inhibitor of Metalloproteinase-1 | 1 | 2007 | 25 | 0.020 |
Why?
|
Body Height | 1 | 2008 | 194 | 0.020 |
Why?
|
Statistics as Topic | 1 | 2008 | 314 | 0.020 |
Why?
|
Indicators and Reagents | 1 | 2007 | 102 | 0.020 |
Why?
|
Body Fluids | 1 | 2007 | 66 | 0.020 |
Why?
|
Early Diagnosis | 1 | 2008 | 242 | 0.020 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2009 | 531 | 0.020 |
Why?
|
Pulmonary Circulation | 1 | 2009 | 455 | 0.020 |
Why?
|
NIH 3T3 Cells | 1 | 2007 | 141 | 0.020 |
Why?
|
Pyridines | 1 | 2010 | 440 | 0.020 |
Why?
|
Lipopolysaccharides | 1 | 2010 | 875 | 0.020 |
Why?
|
Cell Movement | 1 | 2011 | 929 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2012 | 1181 | 0.020 |
Why?
|
Matrix Metalloproteinases | 1 | 2007 | 91 | 0.020 |
Why?
|
Hydrogen-Ion Concentration | 1 | 2007 | 547 | 0.020 |
Why?
|
Hydrogen Peroxide | 1 | 2007 | 299 | 0.020 |
Why?
|
Urban Population | 1 | 2008 | 425 | 0.020 |
Why?
|
Water-Electrolyte Balance | 1 | 2005 | 32 | 0.020 |
Why?
|
SEER Program | 1 | 2006 | 206 | 0.020 |
Why?
|
Respiratory Mechanics | 1 | 2005 | 75 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2007 | 254 | 0.020 |
Why?
|
Introns | 1 | 2006 | 236 | 0.020 |
Why?
|
Exons | 1 | 2006 | 310 | 0.020 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 1423 | 0.020 |
Why?
|
Protein Isoforms | 1 | 2006 | 347 | 0.020 |
Why?
|
Transforming Growth Factor beta | 1 | 2007 | 468 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2007 | 931 | 0.020 |
Why?
|
Body Weight | 1 | 2008 | 958 | 0.010 |
Why?
|
Genomics | 1 | 2008 | 714 | 0.010 |
Why?
|
Nutritional Status | 1 | 2005 | 306 | 0.010 |
Why?
|
Models, Biological | 1 | 2009 | 1756 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2010 | 3799 | 0.010 |
Why?
|
Hypertension, Pulmonary | 1 | 2010 | 1900 | 0.010 |
Why?
|
Pregnancy | 1 | 2009 | 5854 | 0.010 |
Why?
|
Mouth Mucosa | 1 | 1975 | 81 | 0.010 |
Why?
|
Tongue | 1 | 1975 | 74 | 0.010 |
Why?
|
Muscles | 1 | 1975 | 336 | 0.010 |
Why?
|
Ventilation-Perfusion Ratio | 1 | 1976 | 15 | 0.000 |
Why?
|
Lung Volume Measurements | 1 | 1976 | 51 | 0.000 |
Why?
|
Collagen | 1 | 1976 | 436 | 0.000 |
Why?
|
Oxygen Consumption | 1 | 1976 | 613 | 0.000 |
Why?
|